Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.50 |
| ▸ | PGR | P06401 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.50 |
| ▸ | DGKA | P23743 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9571592 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL1006866 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL27637046 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL25329633 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL514798 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL25330787 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL8429929 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL817977 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL514850 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| Ammonia Solution, Strong SCHEMBL3968809 | 0.98 | ALDH1A1 (0.65) | ALDH1A1LMNATSHRCYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1640 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| WO-2024175295-A1 | DETERGENTS AND CLEANING AGENTS COMPRISING DISPERSIN AND FRAGRANCE | HENKEL AG & CO. KGAA (DE) | 2024-08-29 | — | — | WO | claimed |
| US-20240269292-A1 | INTRAVITREAL MITOCHONDRIAL-TARGETED PEPTIDE PRODRUGS AND METHODS OF USE | EYEDEA BIO, LLC | 2024-08-15 | — | — | US | claimed |
| US-20240269320-A1 | EXTENDED RELEASE DRUG DELIVERY SYSTEM FOR OCULAR DRUGS AND METHODS OF USE | EYEDEA BIO, LLC | 2024-08-15 | — | — | US | claimed |
| EP-4256010-B1 | COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2024-07-17 | — | — | EP | claimed |
| CN-117986481-A | Low-yellowing thermoplastic polyvinyl alcohol resin, film and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| EP-4351612-A2 | EXTENDED RELEASE DRUG DELIVERY SYSTEM FOR OCULAR DRUGS AND METHODS OF USE | Eyedea Bio, Llc (US) | 2024-04-17 | — | — | EP | claimed |
| CN-117881411-A | Extended release drug delivery system for ocular drugs and methods of use | 艾迪雅生物有限责任公司 | 2024-04-12 | — | — | CN | claimed |
| EP-4347616-A2 | INTRAVITREAL MITOCHONDRIAL-TARGETED PEPTIDE PRODRUGS AND METHODS OF USE | Eyedea Bio, Llc (US) | 2024-04-10 | — | — | EP | claimed |
| CN-117858888-A | Intravitreal mitochondrial targeting peptide prodrugs and methods of use thereof | 艾迪雅生物有限责任公司 | 2024-04-09 | — | — | CN | claimed |
| EP-0787177-A1 | DETERGENT COMPOSITIONS CONTAINING ENDURING PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1997-08-06 | — | — | EP | claimed |
| US-5540853-A | CLEANING COMPOUNDS, PERFUMES, SURFACTANTS AND CARRIERS | THE PROCTER & GAMBLE COMPANY (US) | 1996-07-30 | — | — | US | claimed |
| WO-1996012468-A1 | PERSONAL TREATMENT COMPOSITIONS AND/OR COSMETIC COMPOSITIONS CONTAINING ENDURING PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012786-A1 | DETERGENT COMPOSITIONS CONTAINING ENDURING PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012467-A1 | PERSONAL TREATMENT COMPOSITIONS AND/OR COSMETIC COMPOSITIONS CONTAINING ENDURING PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1996-05-02 | — | — | WO | claimed |
| US-5500138-A | QUATERNARY AMMONIUM COMPOUND, LONG LASTING PERFUME, BETTER DEPOSITION ON FABRICS | THE PROCTER & GAMBLE COMPANY (US) | 1996-03-19 | — | — | US | claimed |
| US-5500137-A | Fabric softening bar compositions containing fabric softener and enduring perfume | THE PROCTER & GAMBLE COMPANY (US) | 1996-03-19 | — | — | US | claimed |
| US-5439641-A | Undecylenate deodorization of paper mill effluents | ELF ATOCHEM S.A. (FR) | 1995-08-08 | — | — | US | claimed |
| US-5391580-A | Polymer layer directly attached to polypropylene tube and active heparin linked through covalent bond to the layer | ANATRACE INC. (US) | 1995-02-21 | — | — | US | claimed |
| US-3974196-A | Method for disproportionating ethylenically unsaturated compounds having functional ester groups | JAPAN SYNTHETIC RUBBER CO., LTD. (JA) | 1976-08-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240269292-A1 | INTRAVITREAL MITOCHONDRIAL-TARGETED PEPTIDE PRODRUGS AND METHODS OF USE | PDF, PITRM1, ATP5PD | ALDH1A1 1949/4885LMNA 1398/4885TSHR 2224/4885 |
| US-20240269320-A1 | EXTENDED RELEASE DRUG DELIVERY SYSTEM FOR OCULAR DRUGS AND METHODS OF USE | CHMP4B, UACA, VEGFA | ALDH1A1 1229/4885LMNA 2983/4885TSHR 822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.